Related Experiment Video

Updated: Jun 20, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

TGFBR1 haplotypes and risk of non-small-cell lung cancer

Zhe Lei1, Reng-Yun Liu, Jun Zhao

  • 1Laboratory of Medical Genetics, School of Basic Medicine and Biological Sciences, The First Affiliated Hospital, Medical College of Soochow University, Suzhou, PR China.

Cancer Research
|August 20, 2009
PubMed

Insights

A specific TGFBR1 gene variation, the CTGC haplotype, was found to be associated with a reduced risk of developing non-small-cell lung cancer (NSCLC). This finding suggests a potential genetic link to NSCLC susceptibility.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Transforming growth factor beta (TGF-beta) receptors are crucial for cell growth and differentiation.
  • Inactivation of TGF-beta receptors is common in non-small-cell lung cancer (NSCLC).
  • Reduced expression of the type I TGF-beta receptor (TGFBR1) is linked to increased cancer risk.

Purpose of the Study:

  • To investigate the association between TGFBR1 gene variations (SNPs and haplotypes) and the risk of developing NSCLC.
  • To determine if specific TGFBR1 haplotypes confer susceptibility or protection against NSCLC.

Main Methods:

  • Genotyping of seven TGFBR1 haplotype-tagging SNPs (htSNPs) using PCR-RFLP and PCR-single-strand conformation polymorphism assays.
  • Analysis of two independent case-control studies involving Han Chinese participants from Suzhou and Wuxi.
  • Reconstruction of TGFBR1 haplotypes based on genotyping data and linkage disequilibrium.

Main Results:

  • No individual single-nucleotide polymorphism (SNP) was significantly associated with NSCLC risk.
  • A specific four-marker haplotype (CTGC) in TGFBR1 was found to be significantly more prevalent in healthy controls than in NSCLC cases across both studies.
  • This CTGC haplotype demonstrated a strong association with a decreased risk of NSCLC (adjusted OR = 0.11; 95% CI, 0.03-0.39).

Conclusions:

  • The study provides the first evidence linking a specific TGFBR1 haplotype (CTGC) to a reduced risk of NSCLC.
  • This finding suggests that certain TGFBR1 genetic variations may play a protective role against NSCLC development.
  • Further research is warranted to elucidate the functional mechanisms underlying this association.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...